Parla Pharmaceuticals, the first science-based pharmaceutical company in Azerbaijan, has officially announced the launch of production of local medicines to meet the needs of the population and to export. The production facility, which will produce high-tech medicines along with classic medicines, will soon be operational. All pharmaceutical products will meet European and American pharmaceutical standards.
At the initial stage, about 100 medicines will be produced, and in the next 5 years this number will reach 400. Along with classic chemical medicines, modern biotechnological and nanotechnological pharmaceutical products are planned to be produced.
”Our goal is to fully meet the needs of the population with innovative and high-tech medicines and to export these products worldwide. By this way, we will strengthen the country's pharmaceutical industry and support patients' access to quality medicines at affordable prices and promote local production. Local production of medicines will contribute to strengthen the positive trends not only in health, but also in the country's economy as a whole. The steps taken by our esteemed President Ilham Aliyev and First Vice President Mehriban Aliyeva, especially in recent years, to support local production inspire us to move forward with confidence in this area. I am confident that Parla will soon be recognized as a ”Made in Azerbaijan” brand in the world market, ”said Arash Nosrati Heravi, CEO of Parla Pharmaceuticals.